Roivant Sciences Ltd. (ROIV) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2026 | $416.27M | +66.7% |
| 2025 | $249.74M | -67.7% |
| 2024 | $773.95M | -1.0% |
| 2023 | $782.02M | +49.3% |
| 2022 | $523.70M | -0.8% |
| 2021 | $527.69M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2026 | $416.27M | +66.7% |
| 2025 | $249.74M | -67.7% |
| 2024 | $773.95M | -1.0% |
| 2023 | $782.02M | +49.3% |
| 2022 | $523.70M | -0.8% |
| 2021 | $527.69M | — |